Steve Schneible / aacr - At the recent AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers, AACR Immediate Past President Lillian L. Siu, MD, FAACR, announced the AACR Rare Cancers Initiative. Learn more about how this new Initiative will marshal global…
AI Summary: The AACR has unveiled a Rare Cancers Initiative to coordinate researchers, streamline data sharing, and speed therapeutic development for uncommon tumor types. By pooling expertise, funding and networks, the program seeks to overcome the chronic scarcity of trials and resources that leave rare‑cancer patients waiting for attention that’s been hard to come by.
ELCC 2026 showcases lung-cancer trials, new data, and collaborations / 3 months
AstraZeneca deal to bring sunvozertinib to US expands access for EGFR Exon20 patients / 7 days
Phase I lung cancer trials consolidating at top-performing U.S. sites / 3 months
Nine‑year CheckMate‑214 follow‑up confirms durable immunotherapy benefit / 21 days
Teclistamab shows survival benefit prompting earlier use discussions / 5 wks
Introducing ISCO 2026 chairs and program highlights / 3 months
CAR-PRISM trial shows BCMA CAR T effective in high-risk smoldering myeloma / 3 months
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.